Clinical Research for the Development of The Drug Metabolism Investigation Methods with ^<13>C and ^<19>F-MRS
^<13>C和^<19>F-MRS药物代谢研究方法发展的临床研究
基本信息
- 批准号:08457238
- 负责人:
- 金额:$ 2.62万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Dynamic natura1 abundance ^<13> C-magnetic resonance spectroscopy (^<13>C-MRS) studies without proton decoupling were performed in the human liver using commercial 1.5 T MRI equipment. A single tuned custom-made circular shape surface coil with an outer diameter of 20 cm operating at 16.04 MHz was used for ^<13>C study. Seventy-five grams of glucose dissolved in water was administrered for the natural abundance ^<13>C-MRS dynamic study, which lasted for approximately 40 to 60 minutes. Data acquisition was broken into 20 min and 1.7 min blocks. Localized proton shimming with a whole body coil was performed with adequate volume to include the observing area of the surface coil, and the line width of the water signal was less than 20 Hz. The glucose and glycogen spectra were clearly visible at 80 to 120 ppm after oral administration of glucose solution. These data demonstrate that dynamic hepatic carbohydrate metabolism is possible to observe with commercially available MRI equipment. Giv … More en that the human hepatic glycogen pool reaches the maximum level within less than 10 min, it should allow for the direct diagnosis of hepatic carbohydrate metabolic disorders.Natural abundance ^<19>F-magnetic resonance spectroscopy (^<19>F-MRS) on 5-EU based medicines were performed in the human liver using commercial 1.5 T MRI equipment. A single tuned custom- made circular shape surface coil with an diameter of 15 cm operating at 60 MHz was used for ^<19>F- MRS study. Localized proton shimming with a whole body coil was performed with adequate volume to include the observing area of the surface coil, and the line width of the water signal was less than 20 Hz. Normal clinical dose of oral fluorine anticancer medicine should be too small to detect enough signal for the ^<19>F-MRS using commercial MRI equipment. But we can observe very different spectroscopic appearance patterns of 5-FU.We examined whether the pharmacokinetics in the liver of orally administered 1-hexylcarbamoyl-5-fluorouracil (HCFU) differ from those of orally administered 5'-deoxy-5-fluorouridine (5'-DFUR). This preliminary study indicated ^<19>^<19>F-MRS technique should be very useful method to evaluate in vivo 5-FU based medicines metabolism. Less
使用<13><13>商用1.5 T MRI设备在人体肝脏中进行了动态自然丰度~ 13 C-磁共振波谱(~ 13 C-MRS)研究,未进行质子去耦。使用在16.04 MHz下操作的外径为20 cm的单调谐定制圆形表面线圈进行14 <13>C研究。施用75克溶解在水中的葡萄糖用于天然丰度13 <13>C-MRS动态研究,其持续约40至60分钟。数据采集分为20分钟和1.7分钟的块。使用全身线圈进行局部质子匀场,具有足够的体积以包括表面线圈的观察区域,并且水信号的线宽小于20 Hz。口服葡萄糖溶液后,葡萄糖和糖原光谱在80 - 120 ppm处清晰可见。这些数据表明,动态肝脏碳水化合物代谢是可能的,观察与市售MRI设备。Giv ...更多信息 应用1.5T磁共振成像仪对人肝脏进行了天然丰度~ 1F-MRS(Natural丰度~ <19>1F-magnetic resonance <19>spectroscopy)研究。使用一个直径为15 cm的单调谐定制圆形表面线圈,工作频率为60 MHz,用于~ <19>1F-MRS研究。使用全身线圈进行局部质子匀场,具有足够的体积以包括表面线圈的观察区域,并且水信号的线宽小于20 Hz。常规临床口服抗肿瘤药物的剂量太小,以至于<19>用市售MRI设备无法检测到足够的~ 1F-MRS信号。但是我们可以观察到非常不同的5-FU的光谱外观模式。我们研究了口服1-己基氨基甲酰基-5-氟尿嘧啶(HCFU)和口服5 ′-脱氧-5-氟尿嘧啶(5 ′-DFUR)在肝脏中的药代动力学是否不同。初步研究表明,~(<19>13)<19>F-MRS技术是评价5-FU类药物体内代谢的有效方法。少
项目成果
期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ikehira H,Obata T,Koga M,Yoshida K: "Human hepatic carbohydrate metabolism.Dynamic observation using ^<13>C NMR without proton decoupling." Acta Radiologica. 38. 998-1002 (1997)
Ikehira H、Obata T、Koga M、Yoshida K:“人类肝脏碳水化合物代谢。使用 13 C NMR 进行动态观察,无需质子解耦。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
池平博夫: "各種撮影法の特徴、整形外科MRI、" 守屋秀繁・北原 宏編、中外医学社、東京、, (6-11) (1998)
Hiroo Ikehira:“各种成像方法的特点,骨科 MRI”,由 Hideshige Moriya 和 Hiroshi Kitahara 编辑,Chugai Igakusha,东京,(6-11) (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Furuya, H.Ikehira et al.: "The Measurement of Blood Flow Parameters with Deuterium Stable Isot ope MR Imaging." Annals of Nuclear Medicine. 11. 281-284 (1997)
Y.Furuya、H.Ikehira 等人:“利用氘稳定等位线 MR 成像测量血流参数。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
池平博夫 小畠隆行: "臨床医学におけるMR計測" ファルマシア. 32(3). 35-38 (1996)
Hiroo Ikehira 和 Takayuki Obata:“临床医学中的 MR 测量” Pharmacia 32(3) (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Obata T., Ikehira H.et al: "Three-vessel study of cerebral blood flow using phase-contrast megnetic resonance imaging : effect of physical characteristics." Magnetic Resonance Imaging.14. 1143-1148 (1996)
Obata T.、Ikehira H.等人:“使用相衬磁共振成像对脑血流的三血管研究:物理特征的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IKEHIRA Hiroo其他文献
IKEHIRA Hiroo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IKEHIRA Hiroo', 18)}}的其他基金
Development and a medical assessment of the image measurement technique by the 7T400mm grade ultrahigh magnetic field MRI
7T400mm级超高磁场MRI影像测量技术的开发与医学评估
- 批准号:
17390341 - 财政年份:2005
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The development and evaluation of super high resolution MR microscopy.
超高分辨率磁共振显微镜的开发和评估。
- 批准号:
11470187 - 财政年份:1999
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a quantitative diagnostic method of ^<19>F drug metabolism using clinical MRI
利用临床MRI开发^ 19 F药物代谢的定量诊断方法
- 批准号:
11557067 - 财政年份:1999
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
^<19>F-MRSによる心筋細胞内Ca動態計測法の確立とその応用面の開拓
^<19>利用F-MRS测量心内Ca动态的方法的建立及其应用的开发
- 批准号:
07680927 - 财政年份:1995
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)














{{item.name}}会员




